Macmillan Cancer Support
Investor profile
Venture capital
Macmillan Cancer Support has backed 3 European tech companies across 3 funding rounds between 2025 and 2026, joining rounds totalling €21M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2025–2026
2 yrs
Total round €
€21M
sum of rounds joined
Deals by year
distinct rounds / yearMacmillan Cancer Support — deals by year — interactive chart.
Data table
| Macmillan Cancer Support — deals by year | |
|---|---|
| 2025 | 2 |
| 2026 | 1 |
Top sectors
by dealsMacmillan Cancer Support — top sectors — interactive chart.
Data table
| Macmillan Cancer Support — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsMacmillan Cancer Support — stages — interactive chart.
Data table
| Macmillan Cancer Support — stages | |
|---|---|
| Other | 2 |
| Series A | 1 |
Countries
by dealsMacmillan Cancer Support — countries — interactive chart.
Data table
| Macmillan Cancer Support — countries | |
|---|---|
| UK | 3 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Oxcan | UK | 1 | €11M |
| Lucida Medical | UK | 1 | €10M |
| Dxcover | UK | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Oxcan | Series A | €11M | 2025-01 |
| Lucida Medical | Other | €10M | 2026-03 |